Apr 29, 2026 | Uncategorized
By Tom Kutrubes | The original version of this article was published in Lab Manager in January 2026. Lab supply chain risk is the exposure a laboratory takes on when hidden constraints in a vendor’s production, testing, or regulatory process can delay or disrupt...
Jan 14, 2026 | Uncategorized
By Tom Kutrubes When the federal government shut down in 2025, the life sciences community faced an unexpected casualty: a flock of sheep at a National Veterinary Services Laboratories facility. For most, this seemed inconsequential. For biotech companies, contract...
Jun 26, 2025 | Uncategorized
By Tom Kutrubes The global fetal bovine serum (FBS) supply chain is under unprecedented pressure. Environmental disruptions, economic shifts, and evolving regulatory landscapes are converging to create significant challenges for laboratories worldwide. In response to...
Sep 6, 2024 | Uncategorized
By Tom Kutrubes Fetal Bovine Serum (FBS) has long been the cornerstone of cell culture research, praised for its consistent results and reliable supply. Recently, Human Platelet Lysate (hPL) has emerged as a potential alternative, promising similar benefits with a...
Aug 29, 2024 | Uncategorized
By Tom Kutrubes Fetal bovine serum (FBS) has been a cornerstone of scientific research for decades, quietly powering countless breakthroughs in medicine and biotechnology. Behind every major advancement in cell culture, vaccine development, and drug discovery, FBS...
Aug 7, 2024 | Uncategorized
By Tom Kutrubes Choosing the right Fetal Bovine Serum (FBS) is crucial for the success of your research as the quality of FBS can significantly impact the reliability and reproducibility of your results. In this blog, we’ll explore why SeraPrime’s FBS is the...
Recent Comments